Table 4.
Partial correlations between serum L-Carnitine, TMAO levels with components of MS in females and males with normal serum glucose level.
| Male (n = 400) | Female (n = 465) | |||
|---|---|---|---|---|
| r1(P) | r2(P) | r1(P) | r3(P) | |
| L-CARNITINE (μmol/L) | ||||
| Weight | 0.030 (0.549) | 0.017 (0.736) | 0.174 (0.000) | 0.164 (0.000) |
| BMI | 0.053 (0.287) | 0.033 (0.509) | 0.210 (0.000) | 0.157 (0.001) |
| Waist circumference | 0.057 (0.254) | 0.032 (0.522) | 0.223 (0.000) | 0.123 (0.009) |
| Hip circumference | 0.050 (0.316) | 0.025 (0.619) | 0.224 (0.000) | 0.147 (0.002) |
| Waist/hip ratio | 0.046 (0.360) | 0.033 (0.518) | 0.097 (0.037) | 0.017 (0.712) |
| Systolic BP | 0.067 (0.183) | 0.055 (0.276) | 0.072 (0.121) | 0.007 (0.882) |
| Diastolic BP | 0.027 (0.588) | 0.003 (0.956) | 0.052 (0.267) | 0.002 (0.961) |
| Serum TG | 0.149 (0.003) | 0.126 (0.013) | 0.106 (0.023) | 0.029 (0.543) |
| Serum TC | 0.104 (0.037) | 0.072 (0.154) | 0.201 (0.000) | 0.093 (0.047) |
| Serum HDL-c | −0.034 (0.498) | −0.038 (0.458) | −0.051 (0.276) | −0.006 (0.904) |
| Serum LDL-c | 0.068 (0.175) | 0.040 (0.435) | 0.191 (0.000) | 0.078 (0.98) |
| Atherogenic index (AI) | 0.076 (0.130) | 0.051 (0.310) | 0.149 (0.001) | 0.053 (0.257) |
| Serum glucose | −0.016 (0.746) | −0.040 (0.427) | 0.219 (0.000) | 0.092 (0.049) |
| Serum insulin | 0.138 (0.006) | 0.121 (0.016) | 0.123 (0.008) | 0.139 (0.003) |
| HOMA-IR | 0.134 (0.007) | 0.114 (0.024) | 0.149 (0.001) | 0.145 (0.002) |
| HOMA-β | 0.119 (0.017) | 0.093 (0.066) | 0.182 (0.000) | 0.131 (0.005) |
| QUICKI | −0.134 (0.007) | −0.113 (0.026) | −0.147 (0.002) | −0.146 (0.002) |
| TMAO (μmol/L) | ||||
| Weight | −0.073 (0.147) | −0.072 (0.157) | 0.049 (0.289) | 0.039 (0.410) |
| BMI | −0.066 (0.190) | −0.084 (0.096) | 0.053 (0.254) | 0.011 (0.813) |
| Waist circumference | −0.022 (0.658) | −0.062 (0.223) | 0.077 (0.097) | −0.002 (0.964) |
| Hip circumference | −0.027 (0.587) | −0.053 (0.296) | 0.059 (0.203) | 0.004 (0.939) |
| Waist/hip ratio | 0.007 (0.890) | −0.036 (0.474) | 0.054 (0.250) | −0.014 (0.773) |
| Systolic BP | 0.072 (0.150) | 0.063 (0.211) | 0.007 (0.874) | −0.051 (0.278) |
| Diastolic BP | 0.044 (0.380) | 0.015 (0.760) | 0.024 (0.603) | −0.003 (0.948) |
| Serum TG | 0.020 (0.696) | 0.031 (0.540) | 0.129 (0.005) | 0.072 (0.127) |
| Serum TC | 0.076 (0.130) | 0.063 (0.216) | 0.177 (0.000) | 0.085 (0.070) |
| Serum HDL-c | 0.106 (0.034) | 0.075 (0.140) | 0.012 (0.793) | 0.041 (0.380) |
| Serum LDL-c | 0.054 (0.285) | 0.042 (0.411) | 0.169 (0.000) | 0.083 (0.077) |
| Atherogenic index (AI) | −0.035 (0.480) | −0.025 (0.628) | 0.099 (0.033) | 0.023 (0.632) |
| Serum Glucose | −0.012 (0.812) | −0.052 (0.301) | 0.124 (0.007) | 0.029 (0.536) |
| Serum Insulin | −0.026 (0.604) | 0.000 (0.994) | 0.055 (0.240) | 0.072 (0.125) |
| HOMA-IR | −0.027 (0.593) | −0.006 (0.904) | 0.070 (0.131) | 0.072 (0.123) |
| HOMA-β | −0.030 (0.549) | −0.024 (0.633) | 0.095 (0.041) | 0.061 (0.194) |
| QUICKI | 0.031 (0.534) | 0.012 (0.819) | −0.064 (0.166) | −0.068 (0.144) |
r1: correlation coefficient; r2: controlled for age, total caloric intake, physical activity level, medicine status, alcohol intake, smoking status; r3 controlled for age, total calorie intake, physical activity level, medicine status, alcohol intake, smoking status and menopausal status; Statistical significance was set to p < 0.05.